还没打新冠疫苗的人，究竟在担心什么？
送鸡蛋、送水果、送毛巾、送牛奶……
（图片来源：自己做的）
为了让你打新冠疫苗，各地真的操碎了心。
打疫苗是帮你对抗新冠病毒最有效的手段之一，也是如今全国人民都非常关注的热点。
腾讯医典推出《新冠疫苗认知洞察报告》，搜集了8000多份有效调查样本，从接种现状、对新冠疫苗的了解程度和关注度等方面，多角度观察当下国人对新冠疫苗的认知情况。
在这个过程中，我们也发现，在打疫苗这件事面前，许多人有非常多的顾虑，影响到究竟打不打疫苗？
今天就全国人民最关心的9个问题，我们一次性说清！
—1—
—2—
—3—
—4—
—5—
—6—
—7—
—8—
—9—
在像新冠这样的传染病防控面前
没有人是一座孤岛
打疫苗
不仅能保护自己
也能保护其他人
只有当社会中大部分人接种了疫苗
才能形成群体免疫
新冠病毒无法在社会中流行起来
这样每个人都才安全
所以别犹豫了：
让我们一起打疫苗
一起给家更有力的保护！
想看报告全文？
左下角！
戳“阅读原文”
审稿专家：卢学新 | 中国疾控中心病毒病预防控制研究所助理研究员、免疫学博士
参考文献
[1]Polack FP, Thomas SJ, Kitchin N, et al. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine. N Engl J Med. 2020 Dec 31;383(27):2603-2615.
[2]Mulligan MJ, Lyke KE, Kitchin N, et al. Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adults. Nature. 2020;586(7830):589-593.
[3]Dagan N, Barda N, Kepten E, et al. BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting. N Engl J Med. 2021;384(15):1412-1423.
[4]Xia S, Duan K, Zhang Y, et al. Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity Outcomes: Interim Analysis of 2 Randomized Clinical Trials.[J]JAMA. 2020:e2015543.
[5]Xia S, Zhang Y, Wang Y, et al. Safety and immunogenicity of an inactivated SARS-CoV-2 vaccine, BBIBP-CorV: a randomised, double-blind, placebo-controlled, phase 1/2 trial.[J] Lancet Infect Dis. 2020, S1473-3099(20)30831-8.
[6]Zhang YJ, Zeng G, Pan HX, et al. Immunogenicity and Safety of a SARS-CoV-2 Inactivated Vaccine in Healthy Adults Aged 18-59 years: Report of the Randomized, Double-blind, and Placebo-controlled Phase 2 Clinical Trial.[J] medrxiv. 2020 Aug 10.
[7] 新冠病毒疫苗接种情况（截至5月11日）.
http://www.gov.cn/xinwen/2021-04/28/content_5603564.htm
[8]pfizer and biontech confirm high efficacy and no serious safety concerns through up to six months following second dose in updated topline analysis of landmark covid-19 vaccine study. 2021.04.01.
https://www.pfizer.com/news/press-release/press-release-detail/pfizer-and-biontech-confirm-high-efficacy-and-no-serious
[9]Huang B, Dai L, Wang H, et al.Serum sample neutralisation of BBIBP-CorV and ZF2001 vaccines to SARS-CoV-2 501Y.V2.Lancet Microbe. 2021.
[10]Roest S, Hoek RAS, Manintveld OC.BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting.N Engl J Med. 2021 Apr 21;384(20)
[11]Yadav PD, Sapkal GN, Abraham P, et al. Neutralization of variant under investigation B.1.617 with sera of BBV152 vaccinees. BioRxiv. 2021; 2021.04.23.441101v1.
[12]曹雪涛. 医学免疫学. 北京·人民卫生出版社. 2018.
[13]新冠病毒疫苗接种技术指南（第一版）.
http://www.nhc.gov.cn/xcs/yqfkdt/202103/c2febfd04fc5498f916b1be080905771.shtml
[14]Shimabukuro TT, Kim SY, Myers TR, et al.Preliminary Findings of mRNA Covid-19 Vaccine Safety in Pregnant Persons.N Engl J Med. 2021.
[15]世卫组织免疫战略咨询专家组（SAGE）. 辉瑞/生物科技COVID-19疫苗：你需要了解些什么.
https://www.who.int/zh/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine
[16]Davanzo R, Agosti M, Cetin I, et al. Breastfeeding and COVID-19 vaccination: position statement of the Italian scientific societies. Ital J Pediatr. 2021;47(1):45.
[17]世卫组织免疫战略咨询专家组（SAGE）. 辉瑞/生物科技COVID-19疫苗：你需要了解些什么.
https://www.who.int/zh/news-room/feature-stories/detail/who-can-take-the-pfizer-biontech-covid-19--vaccine
[18]WHO.Evidence Assessment: Sinovac/CoronaVac COVID-19 vaccine.https://cdn.who.int/media/docs/default-source/immunization/sage/2021/april/5_sage29apr2021_critical-evidence_sinovac.pdf
[19]CDC.COVID-19 Vaccinations in the United States.https://covid.cdc.gov/covid-data-tracker/#vaccinations
[20]Torjesen I. Covid-19: First UK vaccine safety data are “reassuring,” says regulator BMJ 2021; 372 :n363
[21]柯尊阳, 王宇, 李忠明, 等. mRNA技术及其在传染病疫苗研发中的应用 [J] . 中华微生物学和免疫学杂志,2020,40 (09): 661-667.